Carlos Enrique Tene Pérez

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2018 · 140 citations

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +7

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2019 · 92 citations

Treatment And Prevention, Antiretroviral-naive Adults, Clinical Trials +6

Are there any clinical signs and symptoms that are related to endometriosis in infertile women?

Roberto Matorras, Fernándo Rodríguez, José Ignacio Pijoán et al. · American Journal of Obstetrics and Gynecology · 1996 · 65 citations

Infertility, Fertility, Reproductive Health +8

Pregnancy outcome in patients treated with cervical conization for cervical intraepithelial neoplasia

Fernando Mozo de Rosales, Amparo Villasante, B. Rivero et al. · International Journal of Gynecology & Obstetrics · 2011 · 45 citations · Full text

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

Pedro Cahn, Richard Kaplan, Paul E. Sax et al. · The Lancet HIV · 2017 · 35 citations · Full text

Treatment And Prevention, Antiviral Drug Development, Clinical Trials +9